Home/Filings/4/0001012975-18-001040

4//SEC Filing

TVM Life Science Ventures VII L.P. 4

Accession 0001012975-18-001040

CIK 0001069308other

View on SEC.gov Company Profile

Filed

Aug 21, 8:00 PM ET

Accepted

Aug 22, 4:22 PM ET

Size

14.1 KB

Accession

0001012975-18-001040

Insider Transaction Report

Form 4

Period: 2018-08-01

Acer Therapeutics Inc.ACER

TVM Life Science Ventures VII L.P.

Director10% Owner

Transactions

Purchase
Common Stock
2018-08-01$18.00/sh+275,000$4,950,000→ 1,697,709 total(indirect: See Footnote)

Fischer Stefan

10% Owner

Transactions

Purchase
Common Stock
2018-08-01$18.00/sh+275,000$4,950,000→ 1,697,709 total(indirect: See Footnote)

Beeby Reshentha

10% Owner

Transactions

Purchase
Common Stock
2018-08-01$18.00/sh+275,000$4,950,000→ 1,697,709 total(indirect: See Footnote)

Marengere Luc

10% Owner

Transactions

Purchase
Common Stock
2018-08-01$18.00/sh+275,000$4,950,000→ 1,697,709 total(indirect: See Footnote)

SCHUHSLER HELMUT

10% Owner

Transactions

Purchase
Common Stock
2018-08-01$18.00/sh+275,000$4,950,000→ 1,697,709 total(indirect: See Footnote)

Birner Hubert

Director10% Owner

Transactions

Purchase
Common Stock
2018-08-01$18.00/sh+275,000$4,950,000→ 1,697,709 total(indirect: See Footnote)

Leatt Gary

10% Owner

Transactions

Purchase
Common Stock
2018-08-01$18.00/sh+275,000$4,950,000→ 1,697,709 total(indirect: See Footnote)

Footnotes (1)

[F1]These shares are directly held by TVM Life Science Ventures VII L.P. ("TVM VII LP"). TVM Life Science Ventures VII (GP) Ltd. ("TVM VII GP Ltd") is the general partner of TVM VII LP. Hubert Birner ("Birner"), Stefan Fischer ("Fischer"), Helmut Schuhsler ("Schuhsler"), Luc Marengere ("Marengere"), Reshentha Beeby ("Beeby"), and Gary Leatt ("Leatt") are members of the investment committee of TVM VII GP Ltd, which has voting and investment power with respect to these shares. TVM VII GP Ltd, Birner, Fischer, Schuhsler, Marengere, Beeby and Leatt each disclaim any beneficial ownership of the reported securities, except to the extent of any pecuniary interest therein, if any. Marengere is a director of the Issuer.

Documents

1 file

4
edgar.xmlPrimary
PRIMARY DOCUMENT

Issuer

Acer Therapeutics Inc.

CIK 0001069308

→

Entity typeother

IncorporatedXX

Related Parties

filerCIK 0001640880

Filing Metadata

Form type: 4
Filed: Aug 21, 8:00 PM ET
Accepted: Aug 22, 4:22 PM ET
Size: 14.1 KB

View on SEC.gov